| Medical and Health Sciences | Lifetime | 393 | US 212 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 330 | US 118 | 99.93 |
| Cardiology and Cardiovascular Medicine | Lifetime | 75 | US 41 | 99.94 |
| Surgery | Lifetime | 611 | US 333 | 99.43 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 518 | US 290 | 98.69 |
| Emergency Medicine | Lifetime | 248 | US 139 | 98.05 |
| Agronomy and Crop Science | Lifetime | 475 | US 177 | 96.85 |
| Internal Medicine | Lifetime | 166 | US 64 | 96.39 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 108 | US 54 | 99.47 |
| Surgery | 2021-2025 | 226 | US 89 | 98.61 |
| Biomedical Engineering | 2021-2025 | 263 | US 16 | 98.76 |
| Emergency Medicine | 2021-2025 | 40 | US 16 | 98.11 |
| Internal Medicine | 2021-2025 | 66 | US 24 | 92.45 |
| Acute Myocardial Infarction Research | Lifetime | 18 | US 12 | 99.93 |
| Cardiac Arrest and Resuscitation | Lifetime | 62 | US 33 | 99.70 |
| Cardiac Imaging and Diagnostics | Lifetime | 90 | US 53 | 99.83 |
| Heart Failure Treatment and Management | Lifetime | 61 | US 38 | 99.75 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 56 | US 25 | 99.64 |
| Mechanical Circulatory Support Devices | Lifetime | 78 | US 47 | 99.47 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 138 | US 56 | 99.54 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 171 | US 78 | 99.49 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 245 | US 138 | 99.29 |
| Lipoproteins and Cardiovascular Health | Lifetime | 140 | US 79 | 99.28 |
| Biomarkers in Disease Mechanisms | Lifetime | 26 | US 4 | 98.36 |
| Coronary Interventions and Diagnostics | Lifetime | 198 | US 100 | 99.34 |
| Cardiovascular Function and Risk Factors | Lifetime | 385 | US 217 | 99.29 |
| GDF15 and Related Biomarkers | Lifetime | 20 | US 8 | 98.27 |
| Cardiac Structural Anomalies and Repair | Lifetime | 238 | US 161 | 99.24 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 795 | US 398 | 98.47 |
| COVID-19 Clinical Research Studies | Lifetime | 978 | US 228 | 96.84 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 500 | US 213 | 97.90 |
| Cardiac Fibrosis and Remodeling | Lifetime | 192 | US 77 | 97.12 |
| Long-Term Effects of COVID-19 | Lifetime | 741 | US 176 | 95.20 |
| Reproductive Physiology in Livestock | Lifetime | 547 | US 238 | 97.88 |
| Sepsis Diagnosis and Treatment | Lifetime | 747 | US 273 | 97.04 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 631 | US 231 | 96.27 |
| Potassium and Related Disorders | Lifetime | 235 | US 118 | 95.51 |
| Macrophage Migration Inhibitory Factor | Lifetime | 684 | US 277 | 84.16 |
| Mechanical Circulatory Support Devices | 2021-2025 | 7 | US 4 | 99.80 |
| Cardiac Arrest and Resuscitation | 2021-2025 | 12 | US 4 | 99.77 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 12 | US 4 | 99.69 |
| Heart Failure Treatment and Management | 2021-2025 | 107 | US 44 | 98.78 |
| Acute Myocardial Infarction Research | 2021-2025 | 139 | US 42 | 97.77 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 400 | US 110 | 97.21 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 559 | US 199 | 96.33 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 480 | US 149 | 95.03 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 492 | US 152 | 91.29 |
| Diabetes Treatment and Management | 2021-2025 | 889 | US 287 | 91.21 |
| Potassium and Related Disorders | 2021-2025 | 117 | US 50 | 90.44 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 607 | US 120 | 87.71 |
| GDF15 and Related Biomarkers | 2021-2025 | 139 | US 39 | 78.49 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 447 | US 152 | 62.62 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 980 | US 213 | 60.67 |
| Macrophage Migration Inhibitory Factor | 2021-2025 | 504 | US 79 | 40.34 |
